The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans-Reference-Cited by-同舟云学术

The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans

Published:2019-05-21 Issue:1 Volume:9 Page:
ISSN:2191-219X
Container-title:EJNMMI Research
language:en
Short-container-title:EJNMMI Res

Author:

Thorneloe Kevin S.,Sepp Armin,Zhang Sean,Galinanes-Garcia Laura,Galette Paul,Al-Azzam Wasfi,Vugts Danielle J.,van Dongen Guus,Elsinga Phillip,Wiegers Johan,Glaudemans Andor W. J. M.,Vincent Veena,Renaux Jessica,Szapacs Matt,Birchler Mary,Cleveland Matthew,Bergstrom Mats,Davies Marie^ORCID

Funder

GlaxoSmithKline

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1186/s13550-019-0514-9.pdf

Reference35 articles.

1. Ward ES, Gussow D, Griffiths AD, Jones PT, Winter G. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature. 1989;341:544–6.

2. Jespers L, Schon O, Famm K, Winter G. Aggregation-resistant domain antibodies selected on phage by heat denaturation. Nat Biotechnol. 2004;22:1161–5.

3. Jespers L, Schon O, James LC, Veprintsev D, Winter G. Crystal structure of HEL4, a soluble, refoldable human VH single domain with a germ-line scaffold. J Mol Biol. 2004;337:893–903.